BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30153702)

  • 21. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
    Wang X; Li H; Cui L; Feng J; Fan Q
    Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
    Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
    Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.
    Qi Y; Zhang Y; Peng Z; Wang L; Wang K; Feng D; He J; Zheng J
    J Cell Mol Med; 2018 Feb; 22(2):1224-1235. PubMed ID: 29239102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
    Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
    Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 26. Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
    Yamada Y; Nohata N; Uchida A; Kato M; Arai T; Moriya S; Mizuno K; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2020 Apr; 111(4):1392-1406. PubMed ID: 31975570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
    Chen J; Lou W; Ding B; Wang X
    Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
    Yoshino H; Yonezawa T; Yonemori M; Miyamoto K; Sakaguchi T; Sugita S; Osako Y; Tatarano S; Nakagawa M; Enokida H
    Oncol Rep; 2018 Jan; 39(1):173-181. PubMed ID: 29192325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
    Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
    Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results indicate increased expression of miR-184 in patients with renal carcinoma.
    Yang J; Lai CC; Xian ZM; Wang WQ; Xu BL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6878-6887. PubMed ID: 31486487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway.
    Lian JH; Wang WH; Wang JQ; Zhang YH; Li Y
    Asian Pac J Cancer Prev; 2013; 14(9):5017-21. PubMed ID: 24175769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
    Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
    Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.